Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01HL146498-02
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
National Institutes of Health
Grant: 3U54GM115677-05S1
Rhode Island Center for Clinical and Translational Science
National Institutes of Health
Grant: 5R25HL088992-07
Short-Term Training Program to Increase Diversity in Health-Related Research
National Institutes of Health
Grant: 1P20GM103652-01A1
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
FWCI
2.18
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals